In addition to financial costs, laboratory testing imposes a physical cost on patients. Investigational blood loss is an important contributing factor in hospital-acquired anemia (Wong 2006). A study of 188,447 hospitalizations found that 74% of patients developed hospital-acquired anemia. This increased length of stay by 1.02-1.88 days and was associated with increased mortality (Koch 2013).
The IllumiCare Lab Smart Ribbon™ provides clinicians with a high-level view of the financial and clinical impact of lab orders. We never tell the provider not to order another test. We just provide them with the context they need to make a proper judgment about whether the utility of that next test is worth the cost and patient risk.